Most studies assessing tumor response to neoadjuvant chemotherapy via PET measures have focused on the decrease in SUV measurements after two cycles of chemotherapy. However, recent studies have suggested that other 18F-FDG PET-derived measures may provide a statistically significant higher predictive value.